These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12142790

  • 1. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn.
    Svaldi M, Moroder W, Messner H, Battisti L, Venturi R, Coser P, Mitterer M.
    J Pediatr Hematol Oncol; 2002; 24(5):394-6. PubMed ID: 12142790
    [Abstract] [Full Text] [Related]

  • 2. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, Sakurai M.
    Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R, Murata M, Kami M, Ohtake S, Asou N, Kodera Y, Tomonaga M, Masaki Y, Kusumoto S, Takeuchi J, Matsuda S, Hirai H, Yorimitsu mS, Hamajima N, Seto M, Shimoyama M, Ohno R, Morishima Y, Nakamura S.
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [Abstract] [Full Text] [Related]

  • 4. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H, Motohashi S, Isozumi K, Komatsumoto S, Nara M.
    Acta Haematol; 2002 Jun; 108(1):47-52. PubMed ID: 12145468
    [Abstract] [Full Text] [Related]

  • 5. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
    Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S.
    Blood; 1997 Sep 15; 90(6):2417-28. PubMed ID: 9310493
    [Abstract] [Full Text] [Related]

  • 6. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K.
    Intern Med; 1999 Jul 15; 38(7):547-55. PubMed ID: 10435360
    [Abstract] [Full Text] [Related]

  • 7. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X, Wasserman PG, Bhargava A, Iqbal U, Ragnauth S, Fuchs A.
    Arch Pathol Lab Med; 2004 Aug 15; 128(8):e100-3. PubMed ID: 15270596
    [Abstract] [Full Text] [Related]

  • 8. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S, Otsuka M, Takeshita T, Mizukami K, Suzuki S, Uozumi K, Tashiro Y, Arima N, Hanada S.
    Int J Hematol; 2009 Mar 15; 89(2):188-194. PubMed ID: 19109730
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
    Milush JM, Long BR, Snyder-Cappione JE, Cappione AJ, York VA, Ndhlovu LC, Lanier LL, Michaëlsson J, Nixon DF.
    Blood; 2009 Nov 26; 114(23):4823-31. PubMed ID: 19805616
    [Abstract] [Full Text] [Related]

  • 12. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
    Chen VM, McIlroy K, Loui JP, Fay K, Ward C.
    Pathology; 2003 Aug 26; 35(4):325-9. PubMed ID: 12959763
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia.
    El-Sissy AH, El-Mashari MA, Bassuni WY, El-Swaayed AF.
    J Egypt Natl Canc Inst; 2006 Sep 26; 18(3):244-9. PubMed ID: 17671534
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X, Qing A, Ji P, French SW, Mason H.
    Exp Mol Pathol; 2018 Apr 26; 104(2):130-133. PubMed ID: 29501750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ, Xu L, Ke ZY, Huang LB, Zhang XL, Zhang YC, Luo XQ.
    Pediatr Hematol Oncol; 2011 Apr 26; 28(3):187-93. PubMed ID: 21271777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.